Skip to main content
All lobbying firms

UPSTREAM CONSULTING, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$610,000 Income reported
5 Clients represented
35 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (88278), not by name. Filings under this id have also been reported as UPSTREAM CONSULTING.

 Clients 5
 Reported by year 2 years
  • 2026 $270,000 15 filings
  • 2025 $340,000 20 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 34
  • SENATE 34
  • Health & Human Services, Dept of (HHS) 8
  • Food & Drug Administration (FDA) 7
  • White House Office 7
 Recent filings 35 total
Q3 report
ZIONS THERAPEUTICS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · posted Nov 3, 2026
View → Q3 report
RARE ACCESS ACTION PROJECT
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $15,000 income · posted Nov 3, 2026
View → Q3 terminationNo activity
PRIMUS PHARMACEUTICAL
3rd Quarter 2026 (July 1 - Sep 30) · posted Nov 3, 2026
View → Q3 report
AMERICAN KRATOM ASSOCIATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $47,500 income · posted Nov 3, 2026
View → Q3 report
MANAGEMENT & TRAINING CORPORATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $22,500 income · posted Nov 3, 2026
View → Q2 report
ZIONS THERAPEUTICS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 17, 2026
View → Q2 report
RARE ACCESS ACTION PROJECT
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 17, 2026
View → Q2 report
PRIMUS PHARMACEUTICAL
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · posted Jul 17, 2026
View → Q2 report
AMERICAN KRATOM ASSOCIATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $47,500 income · posted Jul 17, 2026
View → Q2 report
MANAGEMENT & TRAINING CORPORATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $22,500 income · posted Jul 17, 2026
View → Q1 report
ZIONS THERAPEUTICS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted May 4, 2026
View → Q1 report
RARE ACCESS ACTION PROJECT
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $15,000 income · posted May 4, 2026
View → Q1 report
PRIMUS PHARMACEUTICAL
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted May 4, 2026
View → Q1 report
AMERICAN KRATOM ASSOCIATION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $47,500 income · posted May 4, 2026
View → Q1 report
MANAGEMENT & TRAINING CORPORATION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $22,500 income · posted May 4, 2026
View → Q4 report
ZIONS THERAPEUTICS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · posted Jan 30, 2026
View → Q4 report
RARE ACCESS ACTION PROJECT
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $15,000 income · posted Jan 30, 2026
View → Q4 report
PRIMUS PHARMACEUTICAL
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · posted Jan 30, 2026
View → Q4 report
AMERICAN KRATOM ASSOCIATION
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $47,500 income · posted Jan 30, 2026
View → Q4 report
MANAGEMENT & TRAINING CORPORATION
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $22,500 income · posted Jan 30, 2026
View →

Showing the 20 most recent of 35 filings. Search the explorer for "UPSTREAM CONSULTING, INC.".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem